Routine symptom screening identifies substantial supportive care needs before radiotherapy

Among 1,251 patients, 67% receiving curative and 80% receiving palliative radiotherapy reported at least one high-burden concern.

KEY POINTS

  • This retrospective study from University Hospital Würzburg, Germany, evaluated routine patient-reported symptom screening before radiotherapy. Of 1,580 patients treated during 2023, evaluable Integrated Palliative Outcome Scale (IPOS) questionnaires were available for 1,251 (79.1%), comprising 860 patients receiving curative-intent RT and 391 receiving palliative-intent RT. The German-language IPOS used a seven-day recall period and assessed physical, emotional, communication, and practical concerns using 17 scored items. Scores of ≥3 on a 0–4 scale indicated a high or very high burden warranting timely clinical assessment.
  • Most patients reported at least one high-burden symptom or concern before radiotherapy. Such concerns were present in 66.9% of curatively treated patients and 79.5% of palliatively treated patients. The investigators defined a complex needs situation pragmatically as high burden on at least three IPOS items. This threshold was met by 27.0% of the curative group and 49.1% of the palliative group (p<0.001), while 33.1% and 20.5%, respectively, reported no high-burden concerns.
  • Physical and emotional burden were substantially greater in patients receiving palliative RT. At least one high-burden physical concern was reported by 59.3% of palliative versus 30.1% of curative patients, while high emotional burden affected 59.6% versus 42.6%, respectively. Social concerns showed a different pattern, occurring in 27.1% of palliative versus 33.3% of curative patients. These differences reflect distinct patient populations and disease characteristics rather than an independent effect of treatment intent.
  • Weakness, impaired mobility, and pain were the most prevalent physical problems. Moderate-to-very-high weakness was reported by 62.6% of palliative versus 38.3% of curative patients, impaired mobility by 56.0% versus 29.8%, and pain by 47.8% versus 26.1%, respectively. These symptoms were present before radiotherapy and should not be attributed to radiation toxicity. Their frequency demonstrates the importance of documenting baseline functional and symptom status before treatment begins.
  • Psychological and practical concerns affected both treatment groups. Moderate-to-very-high anxiety related to disease and treatment was reported by 63.4% of curative and 69.3% of palliative patients, while anxiety among family members was reported by 71.9% and 81.3%, respectively. Practical problems, including financial, housing, and other everyday concerns, produced moderate-to-very-high burden in 44.0% and 46.8%. These findings suggest that supportive care assessment should extend beyond physical symptoms and include patients' families and social circumstances.
  • Expressed interest in supportive services was lower than the prevalence of reported burden. Information about nutritional counseling was requested by 24.2% of curative versus 16.6% of palliative patients, while specialist pain consultation attracted interest from 8.4% versus 17.4%, respectively. Interest in specialist palliative care was 1.9% versus 7.4%. Among patients reporting high pain burden, interest in specialist pain consultation reached 44.4%, compared with 6.2% among those with little or no pain. However, approximately one-third of responses to service-interest questions were missing or uncertain, and expressed interest is not a validated measure of unmet need.
  • The study demonstrated screening feasibility but did not test whether screening improved care. Evaluable questionnaire data were available for 85.6% of curative patients versus 68.0% of palliative patients, suggesting differential selection. Questionnaire distribution was not standardized, and patients with language barriers, physical limitations, or cognitive impairment may have been underrepresented. IPOS has primarily been validated in advanced illness rather than curative radiotherapy, and the study did not assess whether clinicians reviewed the results, initiated supportive interventions, or improved subsequent quality of life.

CLINICAL TAKEAWAY

Routine patient-reported screening before radiotherapy identified substantial physical, emotional, and practical burdens in patients receiving both curative and palliative treatment. These findings support structured pretreatment symptom assessment, particularly because high symptom burden was common even among curatively treated patients. However, screening should be linked to clinical review and appropriate supportive care pathways, and its effect on patient outcomes requires prospective evaluation.

SOURCE

Strahlentherapie und Onkologie

Browse more research Suggest a correction